Institutional Ownership
Eledon Pharmaceuticals Inc
CUSIP 28617K101COMELDNQ1 2026
13D / 13G Filings
24
Schedule 13D/13G on record
Beneficial Filers
14
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
117
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
24 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Ra Capital Management, L.P. | 13G/A | — | 913.31M | SEC |
| 2 | Feb 13, 2026 | Coastlands Capital LP | 13G/A | 5.0% | — | SEC |
| 3 | Jan 21, 2026 | Blackrock, Inc. | 13G/A | 4.6% | 3.63M | SEC |
| 4 | Nov 24, 2025 | Coastlands Capital LP | 13G | 6.0% | — | SEC |
| 5 | Jul 29, 2025 | The Vanguard Group | 13G | 5.5% | 3.32M | SEC |
| 6 | Jul 17, 2025 | Blackrock, Inc. | 13G | 5.4% | 3.25M | SEC |
| 7 | Feb 14, 2025 | Frazier Life Sciences Public Fund, L.P. | 13G/A | 2.0% | 1.18M | SEC |
| 8 | Feb 14, 2025 | Armistice Capital, LLC | 13G/A | 5.0% | 3.14M | SEC |
| 9 | Nov 14, 2024 | Armistice Capital, LLC | 13G/A | 6.0% | 2.36M | SEC |
| 10 | Nov 5, 2024 | Frazier Life Sciences Public Fund, L.P. | 13G | 4.6% | 2.66M | SEC |
14 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Eledon Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bvf Inc/Il | 6.29M | $19.38M |
| 2 | Blackrock, Inc. | 4.38M | $13.50M |
| 3 | Defilade Capital Management, L.P. | 3.56M | $10.98M |
| 4 | Ensign Peak Advisors, Inc | 2.46M | $7.59M |
| 5 | Zimmer Partners, LP | 1.88M | $5.78M |
| 6 | Geode Capital Management, LLC | 1.79M | $5.52M |
| 7 | Sphera Funds Management Ltd. | 1.77M | $5.46M |
| 8 | Catalio Capital Management, LP | 1.64M | $5.05M |
| 9 | Blue Owl Capital Holdings LP | 1.42M | $4.37M |
| 10 | State Street Corp | 1.15M | $3.56M |